MedTrace Logo

Study Phase III Comparison of Superiority, Open With Blind Appraiser, to Evaluate the Efficacy and Safety of Barium Sulphate 66.7% With V (OPTI-BAR) Compared to Proceedings in Inert Radiological Examinations for the Diagnosis of Diseases for Image the Tratogastrointstinal

NCT01629719 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2012-06-28

No results posted yet for this study

Summary

Phase III clinical study, two samples, with assessor blind for the purpose of evaluating the efficacy and safety of the superiority of the use of barium sulphate 66.7% w/v (Opti-bar) as a contrast X-ray (X-ray).

Conditions

  • X-ray Examinations of the Gastrointestinal Tract

Sponsors & Collaborators

  • Alko Do Brasil Industria e Comercio Ltda

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01629719 on ClinicalTrials.gov